MORBIDITY AND MORTALITY OF ACUTE RENAL FAILURE IN COVID-19 PATIENTS IN INTENSIVE CARE ACCORDING TO WAVES/VARIANTS: MONOCENTRIC STUDY AT THE HOSPITAL OF THE EAST OF ILE-DE-FRANCE SITE OF MEAUX

https://storage.unitedwebnetwork.com/files/1099/52d4afbfeaafdee468f61ea81ee2c3b6.pptx
MORBIDITY AND MORTALITY OF ACUTE RENAL FAILURE IN COVID-19 PATIENTS IN INTENSIVE CARE ACCORDING TO WAVES/VARIANTS: MONOCENTRIC STUDY AT THE HOSPITAL OF THE EAST OF ILE-DE-FRANCE SITE OF MEAUX
Arriel
MAKEMBI BUNKETE
Kazi ANGA MUAMBA kazianga243@gmail.com University of Kinshasa Anesthesia and Resuscitation Kinshasa
Wilfrid MBOMBO pwmbombo@gmail.com University of Kinshasa Anesthesia and Resuscitation Kinshasa
Augustin LONGO LUZAYADIO augustin.longo@gmail.com University of Kinshasa Nephrolgy-dialysis Kinshasa
Patrick MUKUNA mukunamiteopatrick@gmail.com University of Kinshasa Anesthesia and Resuscitation Kinshasa
Martin MUKENGA mukengamartin@gmail.com University of Kinshasa Anesthesia and Resuscitation Kinshasa
Jean-claude MUBENGA jeanclaudemubenga@gmail.com University of Kinshasa Anesthesia and Resuscitation Kinshasa
Dan KANKONDE kankonde1@gmail.com University of Kinshasa Anesthesia and Resuscitation Kinshasa
Tharcisse MABIALA tharcisse.mab@gmail.com University of Kinshasa Anesthesia and Resuscitation Kinshasa
Alphonse EDJOKOLA a.edjokola@ch-ouestguyane.fr University of Kinshasa Anesthesia and Resuscitation Kinshasa
Medard BULABULA k.anga-muamba@ch-ouestguyane.fr University of Kinshasa Anesthesia and Resuscitation Kinshasa
Sébastien EHRMINGER sabastienehrminger@gmail.com Hospital of the east of Île-de-France multi-purpose intensive care unit Meaux
Éric DELPIERRE edelpierre@ghef.fr Hospital of the east of Île-de-France multi-purpose intensive care unit Meaux
Vivien HONG TUAN HA vhongtuanha@ghef.fr Hospital of the east of Île-de-France multi-purpose intensive care unit Meaux
Berthe BARHAYIGA k.anga-muamba@ch-ouestguyane.fr University of Kinshasa Anesthesia and Resuscitation Kinshasa
 

Mechanical ventilation in acute respiratory distress syndrome during SARS-COV2 pneumonitis is responsible for pro-inflammatory and hemodynamic phenomena favoring the development of acute renal failure (AKI). The incidence of AKI varies between 20 to 40% of cases for COVID-19 patients admitted to the intensive care unit, with a very high mortality, but heterogeneous according to the different epidemic waves probably due to the phenomenon of genetic variant of the Virus. The objective of this study was to compare the mortality of COVID-19 patents admitted with ARI admitted to intensive care according to waves and variants.

Descriptive and analytical cross-sectional study conducted with COVID-19 patients with AKI admitted to intensive care covering the period from March 2020 to December 2021, in the multipurpose intensive care unit, site of the Grand Est Francilien hospital, Meaux site. The statistical analysis was performed with SPSS software version 23.0. The square Khi test or Fischer's exact used to compare proportions, the student's T-test to compare averages. The search for associated factors was carried out in logistic regression. The value of p≤ 0.05 was set as the significance level

A total of 86 patients were included in the study, the average age was 65 years and elderly patients (≥ 65 years) were the most represented (58%), the sex ratio M/F was 1.8, they were mostly Caucasian at 82%. Most patients had hypertension (50%), diabetes (39.5%), heart disease (37.2%), dyslipidemia (20.9%), arrhythmia disorder (20.9%). The average duration of admission to intensive care is 21.24 ± 13.59 days, diuresis was normal at admission and decreases with length of hospitalization, average blood pressure is 57.33 mmHg, most of our patients were overweight or obese. A large proportion of patients were included in the 2nd wave compared to other epidemic waves. The beta variant was the majority of 36 patients (41.9%), alpha 26 patients (30.3%), Delta 16 patients (18.6%) and Omicron eight patients (9.3%).46.5% of patients had severe lung involvement with acute respiratory distress syndrome according to the Berlin 2012 classification and received a mean Fi02 of 91.22 ± 9.11 and a PEEP of 12.65 ± 1.76.  Urea and creatinine levels at admission were normal and increased over time to mean averages of 22.78 ± 13.64 and 260 ± 162.74, respectively.  We noted 35% of deaths and when we go back according to the stages of KDIGO, we note 50% in stage III, 33% in stage II and 32% in stage I. the second wave had the highest death rate, however there is a higher case fatality rate in the fourth wave

AKI is common in patients admitted to intensive care for SARS-COV2 infection, it has a significant mortality and lethality depending on the severity of the KDIGO stage of the AKI as well as the associated lung lesions and whose variability has been punctuated by the different epidemic waves and genetic variants of the virus associated with it.

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos